|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 152.60 SEK | +5.68% |
|
+7.31% | -2.93% |
| 20/07 | Danske Bank raises Cellavision target price to 187 kronor (180), reiterates buy - BN | FW |
| 20/07 | DNB Carnegie raises price target for Cellavision to 180 kronor (175), reiterates buy | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Diagnostic & Testing Equipment
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 355M | |||||
| 15.69B | |||||
| 1.74B | - | - | |||
| 1.14B | - | ||||
| 976M | |||||
| 633M | - | - | - | - | - |
- Stock Market
- Stocks
- CEVI Stock
- Charts CellaVision AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
